Who Exports Domperidone from India — 493 Suppliers Behind a $29.6M Market
India's domperidone export market is supplied by 493 active exporters who collectively shipped $29.6M across 4,195 shipments. COMBITIC GLOBAL CAPLET PRIVATE LIMITED leads with a 14.7% market share, followed by INNOVA CAPTAB LIMITED and VANTAGE INTERNATIONAL (INDIA) INC. The top 5 suppliers together control 43.3% of total export value, reflecting a moderately competitive market structure.
Top Domperidone Exporters from India — Ranked by Export Value
COMBITIC GLOBAL CAPLET PRIVATE LIMITED is the leading domperidone exporter from India, holding a 14.7% share of the $29.6M market across 4,195 shipments from 493 exporters. The top 5 suppliers — COMBITIC GLOBAL CAPLET PRIVATE LIMITED, INNOVA CAPTAB LIMITED, VANTAGE INTERNATIONAL (INDIA) INC, MACLEODS PHARMACEUTICALS LTD, CADILA PHARMACEUTICALS LIMITED — collectively control 43.3% of total export value, indicating a competitive market. Individual shares are: COMBITIC GLOBAL CAPLET PRIVATE LIMITED (14.7%), INNOVA CAPTAB LIMITED (8.7%), VANTAGE INTERNATIONAL (INDIA) INC (7.6%), MACLEODS PHARMACEUTICALS LTD (6.5%), CADILA PHARMACEUTICALS LIMITED (5.8%).
Top Domperidone Exporters from India
Ranked by export value · 493 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED PANTOPRAZOLE AND DOMPERIDONE TABLETS (PADOMPERIDONE 10 MG AND LANSOPRAZOLE 30 MGDOMPERIDONE 10 MG AND OMEPRAZOLE 20 MG C | $4.3M | 4 | 14.7% |
| 2 | INNOVA CAPTAB LIMITED PANTOVENT-D (PANTOPRAZOLE & DOMPERIDONEPANTODOM (PANTOPRAZOLE DOMPERIDONE SRPANTOPRAZOLE AND DOMPERIDONE TABLETS (PA | $2.6M | 5 | 8.7% |
| 3 | VANTAGE INTERNATIONAL (INDIA) INC PANTODOM (PANTOPRAZOLE DOMPERIDONE SR | $2.3M | 1 | 7.6% |
| 4 | MACLEODS PHARMACEUTICALS LTD RABEMAC DSR - 2X10'SNUPENTA DSR 40MG/10MG/20MG GEL B/30 NUPE100 3X10MACPROX DP 500 ) 10X10S 180 PAC | $1.9M | 4 | 6.5% |
| 5 | CADILA PHARMACEUTICALS LIMITED DOMPERIDONA 10 MG RAW MATERIAL : DOMPERIDONEEMITOP DOMPERIDONE TABLETS BP 10 MG1X500`SDOMPERIDONE SUSPENSION 5 MG /5 ML 30 ML | $1.7M | 8 | 5.8% |
| 6 | MICRO LABS LIMITED PANTODOM (PANTOPRAZOLE DOMPERIDONE SRPHARMACEUTICAL PRODUCTS HARMLESS MEDICINE-PANTOZISAPHPANTOP D | $1.0M | 15 | 3.5% |
| 7 | MEDREICH LIMITED | $843.6K | 3 | 2.8% |
| 8 | MACLEODS PHARMACEUTICALS LIMITED RABEMAC DSR - 2X10'SNUPENTA DSR 40MG/10MG/20MG GEL B/30 NUPE100 3X10MACPROX DP 500 ) 10X10S 180 PAC | $813.4K | 3 | 2.7% |
| 9 | ARISTO PHARMACEUTICALS PRIVATE LIMITED PANTOP DMACPROX DP 500 ) 10X10S 180 PACNUPENTA D 10X15S | $772.7K | 4 | 2.6% |
| 10 | THE MADRAS PHARMACEUTICALS PANTOPRAZOLE AND DOMPERIDONE TABLETS (PADOMPERIDONE 10 MG AND LANSOPRAZOLE 30 MGPHARMACEUTICAL PRODUCTS HARMLESS MEDICINE-PANTOZISAPH | $614.6K | 1 | 2.1% |
| 11 | INVENTIA HEALTHCARE LIMITED PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE-PANTOZISAPHPANTOP DPANTOP D SAMPLES | $419.2K | 8 | 1.4% |
| 12 | MEDLEY PHARMACEUTICALS LIMITED PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE-PANTOZISAPH"PANZO D MYANMAR REG NO: R2605A8450 PACK SIZE : 10X1 | $372.3K | 4 | 1.3% |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LIMITED "PANZO D MYANMAR REG NO: R2605A8450 PACK SIZE : 10X1 | $365.6K | 2 | 1.2% |
| 14 | AHAAN HEALTHCARE PRIVATE LIMITED RABEMAC DSR - 2X10'SNUPENTA DSR 40MG/10MG/20MG GEL B/30 NUPE100 3X10 | $310.7K | 2 | 1.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Domperidone exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Cadila Pharmaceuticals Limited | Warning Letter issued Oct | Yes | Yes | Not verified | Received FDA Warning Letter in 2014; holds WHO-GMP and EU GMP certifications. |
| Micro Labs Limited | Warning Letter issued Jan | Yes | Yes | Not verified | Received FDA Warning Letter in 2015; holds WHO-GMP and EU GMP certifications. |
| Sun Pharmaceutical Industries Limited | Warning Letter issued May | Yes | Yes | Not verified | Received FDA Warning Letter in 2014; holds WHO-GMP and EU GMP certifications. |
| Combitic Global Caplet Private Limited | Not Listed | Yes | Yes | Not verified | Blacklisted by Indian authorities for failing quality standards; holds WHO-GMP a |
| Intas Pharmaceuticals Limited | Warning Letter issued Nov | Yes | Yes | Not verified | Received FDA Warning Letter in 2023; holds WHO-GMP and EU GMP certifications. |
| Global Pharma Healthcare Private Limited | Warning Letter issued Oct | Yes | Yes | Not verified | Received FDA Warning Letter in 2023; holds WHO-GMP and EU GMP certifications. |
| Emcure Pharmaceuticals Limited | Warning Letter issued in | Yes | Yes | Not verified | Received FDA Warning Letter in 2022; holds WHO-GMP and EU GMP certifications. |
| Dr. Reddy's Laboratories Limited | Warning Letter issued in | Yes | Yes | Not verified | Received FDA Warning Letter in 2015; holds WHO-GMP and EU GMP certifications. |
| Wockhardt Limited | Warning Letter issued in | Yes | Yes | Not verified | Received FDA Warning Letter in 2013; holds WHO-GMP and EU GMP certifications. |
| Apotex Research Private Limited | Warning Letter issued Jan | Yes | Yes | Not verified | Received FDA Warning Letter in 2015; holds WHO-GMP and EU GMP certifications. |
TransData Nexus reviewed the regulatory standing of 10 leading Domperidone exporters from India. 0 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 10 are EU GMP compliant. 9 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Domperidone sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a central hub for the production of Active Pharmaceutical Ingredients (APIs). The city is home to Genome Valley, India's first biotech cluster, and hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. This concentration of industry and advanced R&D infrastructure makes Hyderabad a key player in the production of APIs such as Domperidone.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and is home to companies like Zydus Cadila and Torrent Pharmaceuticals. The region's robust infrastructure and regulatory compliance make it a significant center for the manufacturing of finished pharmaceutical products, including Domperidone formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a crucial export gateway for pharmaceuticals. With a substantial number of pharmaceutical units, this region facilitates the export of drugs to various international markets. Its strategic location and well-developed logistics infrastructure support the distribution of pharmaceuticals, including Domperidone, to global destinations.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi and Nalagarh in Himachal Pradesh form one of Asia's largest pharmaceutical hubs, benefiting from tax incentives and a favorable business environment. The region hosts numerous pharmaceutical companies engaged in the production of a wide range of drugs, including Domperidone. Its strategic location and supportive policies have attracted significant investment in pharmaceutical manufacturing.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Assess Regulatory Compliance: Ensure that suppliers adhere to international quality standards and possess necessary certifications for Domperidone production.
- Evaluate Logistics Infrastructure: Consider the logistical capabilities of each region to ensure efficient transportation and export processes.
- Monitor Market Dynamics: Stay informed about regional policies and market trends that may impact the availability and pricing of Domperidone.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Domperidone exporters from India
INNOVA CAPTAB LIMITED — NPPA sets retail price for Innova Captab's drug
The National Pharmaceutical Pricing Authority (NPPA) fixed the retail price of a combination drug manufactured by Innova Captab Ltd and marketed by Macleods Pharmaceuticals Ltd. - IMPACT: This regulatory action may influence Innova Captab's pricing strategies and market competitiveness, potentially affecting its Domperidone export volumes.
Impact: This regulatory action may influence Innova Captab's pricing strategies and market competitiveness, potentially affecting its Domperidone export volumes.
Common Questions — Domperidone Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which domperidone supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, COMBITIC GLOBAL CAPLET PRIVATE LIMITED leads with 276 recorded shipments worth $4.3M. INNOVA CAPTAB LIMITED (33 shipments) and VANTAGE INTERNATIONAL (INDIA) INC (7 shipments) are also established high-volume exporters.
Q How many domperidone manufacturers are there in India?
India has 493 active domperidone exporters with a combined export market of $29.6M across 4,195 shipments to 115 countries. The top 5 suppliers hold 43.3% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for domperidone from India?
Average FOB unit price: $1.71 per unit, ranging from $0.00 to $440.59. Average shipment value: $7.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 493 verified Indian exporters of Domperidone ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 4,195 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 115 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,195 Verified Shipments
493 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists